Online Exclusive Article

The Relationship of Chemotherapy-Induced Nausea to the Frequency of Pericardium 6 Digital Acupressure

Jiyeon Lee

Suzanne L. Dibble

Marylin Dodd

Donald I. Abrams

Beverly Burns

acupressure, nausea, chemotherapy
ONF 2010, 37(6), E419-E425. DOI: 10.1188/10.ONF.E419-E425

Purpose/Objectives: To explain the relationship between the intensity of chemotherapy-induced nausea (CIN) and the frequency of pericardium 6 (P6) digital acupressure.

Design: Secondary data analysis of a multicenter, longitudinal, randomized, clinical trial.

Setting: Nine community clinical oncology programs and six independent sites in the United States.

Sample: 53 patients with breast cancer who received moderate to highly emetogenic chemotherapy and applied P6 digital acupressure in addition to antiemetics to control CIN.

Methods: A daily log measuring nausea intensity and the frequency of acupressure for 11 days after the administration of chemotherapy. Hierarchical generalized linear modeling procedure (multilevel negative binomial regression) was used for analyzing the data.

Main Research Variables: Nausea intensity and acupressure frequency.

Findings: Participants used acupressure an average of two times per day (SD = 1.84, range 0-10). Women who used acupressure more frequently after the peak of nausea (on day 4) were predicted to have a 0.97-point higher nausea intensity in the acute phase than women who used acupressure less frequently, controlling for the effects of other variables in the model (incidence rate ratio = 1.52, p < 0.01).

Conclusions: Patients with breast cancer whose nausea intensity started higher from the acute phase continued to experience higher symptom intensity during the 11 days after chemotherapy administration and required more frequent acupressure even after the peak of nausea.

Implications for Nursing: Careful assessment and management of acute CIN with continuous monitoring and care of CIN in the delayed phase are important nursing issues in caring for patients receiving chemotherapy.

Jump to a section


    American Cancer Society. (2010). Cancer facts and figures 2010. Atlanta, GA: Author.
    Booth, C. M., Clemons, M., Dranitsaris, G., Joy, A., Young, S., Callaghan, W., … Petrella, T. (2007). Chemotherapy-induced nausea and vomiting in breast cancer patients. Journal of Supportive Oncology, 5, 374-380.
    Dando, T. M., & Perry, C. M. (2004). Aprepitant: A review of its use in the prevention of chemotherapy-induced nausea and vomiting. Drugs, 64, 777-794.
    de Boer-Dennert, M., de Wit, R., Schmitz, P. I., Djontono, J., Beurden, V., Stoter, G., & Verweij, J. (1997). Patient perceptions of the side-effects of chemotherapy: The influence of 5HT3 antagonists. British Journal of Cancer, 76, 1055-1061.
    Dibble, S. L., Chapman, J., Mack, K. A., & Shih, A. S. (2000). Acupressure for nausea: Results of a pilot study. Oncology Nursing Forum, 27, 41-47.
    Dibble, S. L., Luce, J., Cooper, B. A., Israel, J., Cohen, M., & Nussey, B. (2007). Acupressure for chemotherapy induced nausea and vomiting: A randomized clinical trial. Oncology Nursing Forum, 34, 813-820.
    Dodd, M. J., Onishi, K., Dibble, S. L., & Larson, P. J. (1996). Differences in nausea, vomiting, and retching between younger and older outpatients receiving cancer chemotherapy. Cancer Nursing, 19, 155-161.
    Ezzo, J., Vickers, A., Richardson, M. A., Allen, C., Dibble, S. L., Issell, B., … Zhang, G. (2005). Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. Journal of Clinical Oncology, 23, 7188-7198.
    Gach M. R. (1990). Acupressure's potent points. New York, NY: Bantam.
    Griffin, A. M., Butow, P. N., Coates, A. S., Childs, A. M., Ellis, P. M., Dunn, S. M., & Tattersall, M. H. N. (1996). On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993. Annals of Oncology, 7, 189-195.
    Grote, T., Hajdenberg, J., Cartmell, A., Ferguson, S., Ginkel, A., & Charu, V. (2006). Combination therapy for chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: Palonosetron, dexamethasone, and aprepitant. Journal of Supportive Oncology, 4, 403-408.
    Herrstedt, J. (2008). Antiemetics: An update and the MASCC guidelines applied in clinical practice. Nature Clinical Practice. Oncology, 5, 32-43.
    Hyde, E. (1989). Acupressure therapy for morning sickness. A controlled clinical trial. Journal of Nurse-Midwifery, 34, 171-178.
    Italian Group for Antiemetic Research. (1994). Cisplatin-induced delayed emesis: Pattern and prognostic factors during three subsequent cycles. Annals of Oncology, 5, 585-589.
    Italian Group for Antiemetic Research. (1997). Delayed emesis induced by moderately emetogenic chemotherapy: Do we need to treat all patients? Annals of Oncology, 8, 561-567.
    Italian Group for Antiemetic Research. (2000). Prevention of cisplatin-induced delayed emesis: Still unsatisfactory. Supportive Care in Cancer, 8, 229-232.
    Kaptchuk, T. J. (2002). Acupuncture: Theory, efficacy, and practice. Annals of Internal Medicine, 136, 374-383.
    Kovac, A. L. (2003). Benefits and risks of newer treatments for chemotherapy-induced and postoperative nausea and vomiting. Drug Safety, 26, 227-259.
    Lee, J., Dibble, S. L., Pickett, M., & Luce, J. (2005). Chemotherapy-induced nausea/vomiting and functional status in women treated for breast cancer. Cancer Nursing, 28, 249-255.
    Liangyue, D., Yijun, G., Shuhui, H., Xiaoping, J., Yang, L., & Rufen, W. (1987). Chinese acupuncture and moxibustion. Beijing, China: Foreign Language Press.
    Lindley, C., Goodin, S., McCune, J., Kane, M., Amamoo, M. A., Shord, S., … Socinski, M. A. (2005). Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: Comparison of ondansetron, prochlor-perazine, and dexamethasone. American Journal of Clinical Oncology, 28, 270-276.
    Massaro, A. M., & Lenz, K. L. (2005). Aprepitant: A novel antiemetic for chemotherapy-induced nausea and vomiting. Annals of Pharmacotherapy, 39, 77-85.
    Molassiotis, A., Helin, A. M., Dabbour, R., & Hummerston, S. (2007). The effects of P6 acupressure in the prophylaxis of chemotherapy-related nausea and vomiting in breast cancer patients. Complementary Therapies in Medicine, 15, 3-12.
    Molassiotis, A., Saunders, M. P., Valle, J., Wilson, G., Lorigan, P., Wardley, A., … Rittenberg, C. (2008). A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre. Supportive Care in Cancer, 16, 201-208.
    National Comprehensive Cancer Network. (2008). NCCN Clinical Practice Guidelines in Oncology™: Antiemesis. Retrieved from
    Navari, R. M. (2003). Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting Two new agents. Journal of Supportive Oncology, 1, 89-103.
    Price, H., Williams, C. J., & Sergiou, K. (1992). A randomized trial of acupressure for chemotherapy induced emesis [Abstract 1394]. Proceedings of ASCO, San Diego, CA: American Society of Clinical Oncology.
    Rhodes, V. A., & McDaniel, R. W. (1999). The Index of Nausea, Vomiting, and Retching: A new format of the Index of Nausea and Vomiting. Oncology Nursing Forum, 26, 889-894.
    Rhodes, V. A., & McDaniel, R. W. (2001). Nausea, vomiting, and retching: Complex problems in palliative care. CA: A Cancer Journal for Clinicians, 51, 232-248.
    Rhodes, V. A., Watson, P. M., & Johnson, M. H. (1984). Development of reliable and valid measures of nausea and vomiting. Cancer Nursing, 7, 33-41.
    Rhodes, V. A., Watson, P. M., Johnson, M. H., Madsen, R. W., & Beck, N. C. (1987). Patterns of nausea, vomiting, and distress in patients receiving antineoplastic drug protocols. Oncology Nursing Forum, 14(4), 35-44.
    Roila, F., Tonato, M., Basurto, C., Canaletti, R., Morsia, D., Passalacqua, R., … Ballatori, E. (1985). Antiemetic activity of two different high doses of metoclopramide in cisplatin-treated cancer patients: A randomized double-blind trial of the Italian Oncology Group for Clinical Research. Cancer Treatment Reports, 69, 1353-1357.
    Roila, F., Tonato, M., Basurto, C., Picciafuoco, M., Bracarda, S., Donati, D., … Patoia, L. (1989). Protection from nausea and vomiting in cisplatin-treated patients: High-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine. Journal of Clinical Oncology, 7, 1693-1700.
    Roscoe, J. A., Jean-Pierre, P., Morrow, G. R., Hickok, J. T., Issell, B., Wade, J. L., & King, D. K. (2006). Exploratory analysis of the usefulness of acupressure bands when severe chemotherapy-related nausea is expected. Journal of the Society for Integrative Oncology, 4, 16-20.
    Roscoe, J. A., Morrow, G. R., Hickok, J. T., Bushunow, P., Pierce, H. I., Flynn, P. J., … Atkins, J. N. (2003). The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting. A University of Rochester Cancer Center Community Clinical Oncology Program. Journal of Pain and Symptom Management, 26, 731-742.
    Shanghai College of Traditional Medicine. (1981). Acupuncture: A complete text. Chicago, IL: Eastland Press.
    Shin, Y. H., Kim, T. I., Shin, M. S., & Juon, H. S. (2004). Effect of acupressure on nausea and vomiting during chemotherapy cycle for Korean postoperative stomach cancer patients. Cancer Nursing, 27, 267-274.
    Stux, G., & Pomeranz, B. (2003). Basics of acupuncture (5th ed.). Berlin, NY: Springer.
    Worsley, J. R. (1982). Traditional Chinese acupuncture. Wiltshire, Wales: Element.